Efficacy and safety of Tinospora cordifolia (Tc) as an add-on therapy in patients with type-2 diabetes

Saumya Mishra, Narsingh Verma, Sandeep Bhattacharya, Kauser Usman, Himanshu Reddy, Neera Verma, Baby Anjum, Prerna Singh, Shipra Bharadwaj, Kshitij Bharadwaj


Background: Type 2 diabetes has become a global epidemic. Tinospora cordifolia is being used in the treatment of type 2 diabetes since ancient times. It is a common misconception that Ayurvedic medicines are always safe. In fact, they also pose serious health risks either in the form of adverse reactions or in the form of drug interactions. Hence this study was undertaken to study the efficacy and safety of Tc on human subjects.

Methods: We recruited 40 type 2 diabetic patients who were on oral hypoglycaemic agents. These patients were then randomly divided into two groups, A and B. Patients in group A continued with their anti-diabetic medications while in group B Tc was given at a dose of 500 mg three times daily along with their conventional medications. The fasting and post prandial blood glucose levels, renal function tests and liver function tests were recorded at baseline, 3 months and 6 months.

Results: During the course of study we observed a decrease in the fasting and post prandial blood glucose levels of the patients. No significant change was observed in the renal function tests and liver function tests and no other event of any adverse drug reactions were recorded.

Conclusion: Tinospora cordifolia (Tc) is effective as an add-on therapy in patients with type-2 diabetes. There is no negative impact of Tc on the renal as well as liver function tests.



Type 2 diabetes, Tinospora cordifolia, Oral hypoglycaemic agents

Full Text:



Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes - a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract. 2000;50 (Suppl 2):S77-84.

Bloomgarden ZT. New and traditional treatment of glycemia in NIDDM. Diabetes Care. 1996;19:295-9.

U.K. Prospective Diabetes Study Group. U.K. prospective diabetes study 16. Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes. 1995;44:1249-58.

Michael PK, Asim AB, Robert SB. The utility of oral diabetes medications in type 2 diabetes of the young. Curr Diab Rev. 2005;1:83-92.

Dey L, Attele AS, Yuan CS. Alternative therapies for type 2 diabetes. Altern Med Rev. 2002;7:45-58.

DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med. 1999;131:281-303.

Venkatesh S, Reddy GD, Reddy BM, Ramesh M, Apparao AVN. Antihyperglycemic activity of Carulluma asttenuate. Fitoterapia. 2003;74:274-7.

Grover JK, Vats V. Shifting paradigam “from conventional to alternative medicine” An introduction on traditional Indian medicine. Asia Pac Biotech News. 2001;5:28-32.

Eddouks M, Maghrani M. Phlorizin-like effect of Fraxinus excelsior in normal and diabetic rats. J Ethnopharmacol. 2004;9:149-54.

Prince PS, Kamalakkannan N, Menon VP. Restoration of antioxidants by ethanolic Tinospora cordifolia in alloxan-induced diabetic wistar rats. Acta Pol Pharm. 2004;61:283-7.

Mathew S, Kuttan G. Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity. J Exp Clin Cancer Res. 1997;16:407-11.

Stanely Mainzen Prince P, Menon VP. Antioxidant action of Tinospora cordifolia root extract in alloxan diabetic rats. Phytother Res. 2001;15:213-8.

Anonymous. Wealth of India. In: CSIR, eds. Raw Materials, Vol X. New Delhi: CSIR; 1976.

Nadkarni KM, Nadkarni AK. Indian materia medica. In: Nadkarni KM, Nadkarni AK, eds. A Book. 3rd ed. Mumbai: M/S Popular Prakasan Pvt. Ltd; 1976.

Singh SS, Pandey SC, Srivastava S, Gupta VS, Patro B, Ghosh AC. Chemistry and medicinal properties of Tinospora cordifolia (Guduchi). Indian J Pharmacol (IJP). 2003;35:83-91.

Nayampalli SS, Ainapure SS, Samant BD, Kudtarkar RG, Desai NK, Gupta KC. A comparative study of diuretic effects of Tinospora cordifolia and hydrochloro-thiazide in rats and a preliminary phase I study in human volunteers. J Postgrad Med. 1988;34:233-6.

Nagaraja PK, Kammar KF, Devi S. Modulation of morphology and some gluconeogenic enzymes activity by Tinospora cordifolia (Willd.) in diabetic rat kidney. Biomed Res. 2007;18:179-83.

Karkal YR, Bairy LK. Safety of aqueous extract of Tinospora cordifolia (Tc) in healthy volunteers: a double blind randomised placebo controlled study. Iranian J Pharmacol Therap. 2007;6:59-61.

Nagarkatti DS, Rege NN, Desai NK, Dahanukar SA. Modulation of Kupffer cell activity by Tinospora cordifoliain liver damage. J Postgrad Med. 1994;40:65-7.

Adhvaryu MR, Reddy N, Vakharia BC. Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach. World J Gastroenterol. 2008;14:4753- 62.

Panchabhai TS, Ambarkhane SV, Joshi AS, Samant BD, Rege NN. Protective effect of Tinospora cordifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: An experimental study. Phytother Res. 2008;22:646-50.

Upadhyay L, Mehrotra A, Srivastava AK, Rai NP, Tripathi K. An experimental study of some indigenous drugs with special reference to hydraulic permeability. Indian J Exp Biol. 2001;39:1308-10.

Rege N, Bapat RD, Koti R, Desai NK, Dahanukar S. Immunotherapy with Tinospora cordifolia: a new lead in the management of obstructive jaundice. Indian J Gastroenterol. 1993;12:5-8.

Mehrotra R, Katiyar CK, Gupta AP. Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection. US Patent. 2000;749:296.

Anonymous. Quality standards of Indian medicinal plants. In: Gupta AK, eds. A Book. Vol 1. New Delhi: Indian Council of Medical Research; 2003: 212.